Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

Outcome after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is adversely affected by relapse to a considerable degree. To exploit the graft-versus-leukemia effect more effectively, we assessed the feasibility of early initiation of epigenetic therapy with panobinostat and decitabine...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Kalin, Burak, van Norden, Yvette, van Gelder, Michel, Breems, Dimitri, Maertens, Johan, Jongen-Lavrencic, Mojca, Broers, Annoek E. C., Braakman, Eric, Grob, Tim, Zeijlemaker, Wendelien, Ossenkoppele, Gert J., Meijer, Ellen, Cornelissen, Jan J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509859/
https://ncbi.nlm.nih.gov/pubmed/32936907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002074
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars